Without the proper evidence for digital health products (DHPs), stakeholders across the healthcare ecosystem, including payers, will encounter obstacles that can result in companies being unable to bring their products to market. Evidence is needed to determine the reliability and value of DHPs and ensure commercial success.
To help, DiMe collaborated with healthcare stakeholders to create Evidence in Digital Health for EFfectiveness of INterventions with Evaluative Depth (Evidence DEFINED) – the new standard of excellence framework for evaluating the clinical assessment of DHPs and defines ‘what good looks like’ when it comes to evidence evaluation.
